PannTheraPi
Phase 1Panntherapi innovates by selectively targeting the activated pannexin 1 channel, involved in the root cause of the diseases
Founded
2019
Focus
Small Molecules
About
Panntherapi innovates by selectively targeting the activated pannexin 1 channel, involved in the root cause of the diseases
Company Info
TypePrivate
Founded2019
LocationParis, France
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile